Reply to ‘Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects’

被引：0
|
作者：
David A. Sykes
J. Robert Lane
Monika Szabo
Ben Capuano
Jonathan A. Javitch
Steven J. Charlton
机构：
[1] University of Nottingham,School of Life Sciences, Queen’s Medical Centre
[2] University of Birmingham and University of Nottingham,Centre of Membrane and Protein and Receptors (COMPARE)
[3] Monash University,Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences
[4] Monash University,Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences
[5] Columbia University,Department of Psychiatry
[6] New York State Psychiatric Institute,Integrative Neuroscience
[7] Columbia University,Department of Pharmacology
[8] Excellerate Bioscience Ltd,undefined
来源：
Nature Communications | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reply to 'Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects'
    Sykes, David A.
    Lane, J. Robert
    Szabo, Monika
    Capuano, Ben
    Javitch, Jonathan A.
    Charlton, Steven J.
    NATURE COMMUNICATIONS, 2018, 9
  • [2] Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects
    Zeberg, Hugo
    Sahlholm, Kristoffer
    NATURE COMMUNICATIONS, 2018, 9
  • [3] Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects
    Hugo Zeberg
    Kristoffer Sahlholm
    Nature Communications, 9
  • [4] Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
    Sykes, David A.
    Moore, Holly
    Stott, Lisa
    Holliday, Nicholas
    Javitch, Jonathan A.
    Lane, J. Robert
    Charlton, Steven J.
    NATURE COMMUNICATIONS, 2017, 8
  • [5] Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
    David A. Sykes
    Holly Moore
    Lisa Stott
    Nicholas Holliday
    Jonathan A. Javitch
    J. Robert Lane
    Steven J. Charlton
    Nature Communications, 8
  • [6] BLOCKADE OF HIPPOCAMPAL DOPAMINE (DA) RECEPTORS - A TOOL FOR ANTIPSYCHOTICS WITH LOW EXTRAPYRAMIDAL SIDE-EFFECTS
    BISCHOFF, S
    CHRISTEN, P
    VASSOUT, A
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (04): : 455 - 467
  • [7] Extrapyramidal side-effects and dopamine D2/3 receptor binding in substantia nigra
    Tuppurainen, Heli
    Kuikka, Jyrki T.
    Viinamaki, Heimo
    Husso, Minna
    Tiihonen, Jari
    NORDIC JOURNAL OF PSYCHIATRY, 2010, 64 (04) : 233 - 238
  • [8] On the extrapyramidal side-effects of antipsychotics with combined dopamine and 5-HT-blocking effects
    Sher, L
    MEDICAL HYPOTHESES, 1998, 50 (03) : 267 - 268
  • [9] Relationship between dopamine D2 gene polymorphism and extrapyramidal side effects of selective dopamine antagonists
    Kondo, T
    Mihara, K
    Suzuki, A
    Yasui-Furukori, N
    Ono, S
    Kaneko, S
    Otani, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S78 - S78
  • [10] Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol
    Schönfeldt-Lecuona, C
    Juengling, FD
    Connemann, BJ
    Reske, SN
    Spitzer, M
    Kassubek, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (01) : 97 - 98
12345